A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors (Q33413979)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors |
scientific article |
Statements
1 reference
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors (English)
1 reference
Amita Patnaik
1 reference
Patricia M LoRusso
1 reference
Wells A Messersmith
1 reference
Kyriakos P Papadopoulos
1 reference
Lia Gore
1 reference
Muralidhar Beeram
1 reference
Vanitha Ramakrishnan
1 reference
Amy H Kim
1 reference
Joseph C Beyer
1 reference
L Mason Shih
1 reference
Walter C Darbonne
1 reference
Yan Xin
1 reference
Ron Yu
1 reference
Hong Xiang
1 reference
Rainer K Brachmann
1 reference
Colin D Weekes
1 reference
17 March 2014
1 reference
1 reference
73
1 reference
951-960
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference